Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Geraldine Cahillane"'
Autor:
Elisabeth Sonesson, Peter Verhamme, Kathelijne Peerlinck, Jean-Marie Saint-Remy, Torben Balchen, Kristina Berggren, Steve Pakola, Steven Glazer, Geraldine Cahillane, Thomas Jensen, Ann Belmans, Marc Jacquemin, Jean-Marie Stassen
Publikováno v:
Clinical Therapeutics. 32:1205-1220
Background: TB-402, a human monoclonal antibody that partially inhibits Factor VIII activity (FVIII:C), is being developed as a long-acting antithrombotic agent. Objectives: The primary goal of this study was to investigate the tolerability of TB-402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b81a3c1441791d2d52872a58f3e22a
https://doi.org/10.1016/j.clinthera.2010.06.012
https://doi.org/10.1016/j.clinthera.2010.06.012
Autor:
Geraldine Cahillane, Jane M. Boswick, S. Michael Harrill, Taylor J. Crouch, Susan M. Meloy, Hugh R. Watson
Publikováno v:
Drug Information Journal. 33:1033-1052
Globalization of clinical trials, and the complexity surrounding the execution of these trials, has stimulated pharmaceutical companies to review their decision making processes to include input from affiliates and outsourced vendors that will be inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::058b47a4808c6a9a058f42f7f6ebd205
https://doi.org/10.1177/009286159903300408
https://doi.org/10.1177/009286159903300408
Publikováno v:
Clinical therapeutics. 31(8)
Background: Microplasmin is the isolated proteinase domain of plasmin. Administration of microplasmin has been found to neutralize α 2 -antiplasmin (α 2 -AP) activity, which has been associated with reduced infarct size in various preclinical model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d62cde5280e3cdafec9164cec97779
https://pubmed.ncbi.nlm.nih.gov/19808128
https://pubmed.ncbi.nlm.nih.gov/19808128